These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6980565)

  • 1. Morphological aspects of lymphocyte mediated cytotoxicity.
    Sanderson CJ
    Adv Exp Med Biol; 1982; 146():3-21. PubMed ID: 6980565
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of human T-lymphocyte antigens by natural killer cells.
    Kaplan J; Callewaert DM
    J Natl Cancer Inst; 1978 May; 60(5):961-4. PubMed ID: 305967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of human lymphocyte subpopulations responsible for antibody-dependent and spontaneous cell-mediated cytotoxicity.
    Perussia B; Trinchieri G; Cerottini JC
    Transplant Proc; 1979 Mar; 11(1):793-5. PubMed ID: 313102
    [No Abstract]   [Full Text] [Related]  

  • 4. Frequency determination of killer cells by a single-cell cytotoxic assay.
    Bonavida B; Bradley TP; Grimm EA
    Methods Enzymol; 1983; 93():270-80. PubMed ID: 6408349
    [No Abstract]   [Full Text] [Related]  

  • 5. Distinctions between NK cells and CTL.
    Henney CS
    Adv Exp Med Biol; 1982; 146():353-6. PubMed ID: 6980566
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic control of natural cytotoxicity and hybrid resistance.
    Clark EA; Harmon RC
    Adv Cancer Res; 1980; 31():227-85. PubMed ID: 6157312
    [No Abstract]   [Full Text] [Related]  

  • 7. Modulation of cytotoxic T lymphocyte, natural killer cell, antibody-dependent cellular cytotoxicity, and antibody-dependent complement-mediated cytotoxicity by Vernonia cinerea L. and vernolide-A in BALB/c mice via enhanced production of cytokines IL-2 and IFN-γ.
    Pratheeshkumar P; Kuttan G
    Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):46-55. PubMed ID: 22176676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [T x B hybrid clones capable of inhibiting the development of leukosis in vivo].
    Petrov RV; Sidorovich IG; Ignat'eva GA; Fuks BB
    Dokl Akad Nauk SSSR; 1983; 269(2):504-8. PubMed ID: 6602039
    [No Abstract]   [Full Text] [Related]  

  • 9. [Natural killers and macrophages: their activity in leukemias].
    Fi FT
    Eksp Med Morfol; 1985; 24(2):63-70. PubMed ID: 3933945
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification and separation of Thy-1 positive mouse spleen cells active in natural cytotoxicity and antibody-dependent cell-mediated cytotoxicity.
    Mattes MJ; Sharrow SO; Herberman RB; Holden HT
    J Immunol; 1979 Dec; 123(6):2851-60. PubMed ID: 387876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and characterization of human leukemia-associated antigens on leukemic cell lines and thymocytes. I. Characterization of baboon and rabbit antisera to MOLT-4.
    Yoshizaki K; Seon BK; Barcos MP; Minowada J; Pressman D
    J Immunol; 1979 May; 122(5):1943-50. PubMed ID: 109520
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence for T cell nature and heterogeneity within natural killer (NK) and antibody-dependent cellular cytotoxicity (ADCC) effectors: a comparison with cytolytic T lymphocytes (CTL).
    Fast LD; Hansen JA; Newman W
    J Immunol; 1981 Aug; 127(2):448-52. PubMed ID: 6788841
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune system. Complement-like cytotoxicity?
    Reid KB
    Nature; 1986 Aug 21-27; 322(6081):684. PubMed ID: 3528860
    [No Abstract]   [Full Text] [Related]  

  • 14. The beige mutation in the mouse selectively impairs natural killer cell function.
    Roder J; Duwe A
    Nature; 1979 Mar; 278(5703):451-3. PubMed ID: 313007
    [No Abstract]   [Full Text] [Related]  

  • 15. A new model for leukemia-lymphoma metastasis: differential growth and rejection of murine lymphoid-leukemia cell lines in the bone marrow.
    Kamenov B; Kieran MW; Leigh JB; Greenberg AH; Longenecker BM
    Symp Fundam Cancer Res; 1983; 36():245-64. PubMed ID: 6679093
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell-mediated immunity in cytomegalovirus infections--a review.
    Quinnan GV; Ennis FA
    Comp Immunol Microbiol Infect Dis; 1980; 3(3):283-90. PubMed ID: 6258855
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibacterial activity against Streptococcus pneumoniae by mouse lung lymphocytes.
    Sestini P; Nencioni L; Villa L; Boraschi D; Tagliabue A
    Adv Exp Med Biol; 1987; 216A():517-25. PubMed ID: 3500582
    [No Abstract]   [Full Text] [Related]  

  • 18. Murine T cells that lyse antibody-sensitized target cells. I. Kinetics and dose-response studies of control and cortisone-resistant thymocytes.
    Lamon EW; Williams BR; Fuson EW; Whitten HD; Walia AS
    J Immunol; 1978 Jan; 120(1):244-8. PubMed ID: 304867
    [No Abstract]   [Full Text] [Related]  

  • 19. The primacy of humoral antibody (complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity) in concordant xenograft rejection.
    Araneda D; Thomas FT; Ljung T; Cekada E; Pittman K
    Transplant Proc; 1995 Feb; 27(1):268-9. PubMed ID: 7878997
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoclonal antibodies against leucoagglutinin-reactive human T lymphocyte surface components. Two antibodies which inhibit cell-mediated cytotoxicity at a post-binding stage.
    Vargas-Cortes M; Hammarström ML; Hammarström S; Hellström U; Perlmann P
    Eur J Immunol; 1986 Jul; 16(7):795-801. PubMed ID: 3522246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.